Computer-aided drug design and in silico pharmacokinetics predictions of some potential antipsychotic agents

Computer-aided drug design and in silico pharmacokinetics predictions of some potential antipsychotic agents

The target of many drugs for the treatment of psychiatric disorders and other related neurological conditions are majorly relied on monoaminergic systems. In continuation of our previous study, computer-aided drug design approach was employed to design some new inhibitors of norepinephrine transport...

Full description

Bibliographic Details
Main Authors:	Sabitu Babatunde Olasupo, Adamu Uzairu, Gideon Adamu Shallangwa, Sani Uba
Format:	Article
Language:	English
Published:	Elsevier 2021-07-01
Series:	Scientific African
Subjects:	Antipsychotic ADMET Pharmacokinetics Design Drug QSAR
Online Access:	http://www.sciencedirect.com/science/article/pii/S2468227621000387

Similar Items

Chemoinformatic studies on some inhibitors of dopamine transporter and the receptor targeting schizophrenia for developing novel antipsychotic agents
by: Sabitu Babatunde Olasupo, et al.
Published: (2020-07-01)

Quantitative Structure-Activity Relationship (QSAR) Studies and Molecular docking Simulation of Norepinephrine Transporter (NET) Inhibitors as Anti-psychotic Therapeutic Agents
by: Sabitu Babatunde OLASUPO, et al.
Published: (2020-02-01)

Unveiling novel inhibitors of dopamine transporter via in silico drug design, molecular docking, and bioavailability predictions as potential antischizophrenic agents
by: Sabitu Babatunde Olasupo, et al.
Published: (2021-03-01)

Profiling the antidepressant properties of phenyl piperidine derivatives as inhibitors of serotonin transporter (SERT) via cheminformatics modeling, molecular docking and ADMET predictions.
by: Sabitu Babatunde Olasupo, et al.
Published: (2020-09-01)

In silico evaluation of some 4-(quinolin-2-yl)pyrimidin-2-amine derivatives as potent V600E-BRAF inhibitors with pharmacokinetics ADMET and drug-likeness predictions
by: Abdullahi Bello Umar, et al.
Published: (2020-09-01)

QSAR analysis and molecular docking simulation of norepinephrine transporter (NET) inhibitors as anti-psychotic therapeutic agents
by: Sabitu Babatunde Olasupo, et al.
Published: (2019-10-01)

Quantitative structure-activity relationship, molecular docking, drug-likeness, and pharmacokinetic studies of some non-small cell lung cancer therapeutic agents
by: Muhammad Tukur Ibrahim, et al.
Published: (2020-12-01)

Computer-aided molecular modeling studies of some 2, 3-dihydro-[1, 4] dioxino [2, 3-f] quinazoline derivatives as EGFRWT inhibitors
by: Muhammad Tukur Ibrahim, et al.
Published: (2020-04-01)

Structure-based design and activity modeling of novel epidermal growth factor receptor kinase inhibitors; an in silico approach
by: Muhammad Tukur Ibrahim, et al.
Published: (2020-09-01)

QSAR, molecular docking studies, ligand-based design and pharmacokinetic analysis on Maternal Embryonic Leucine Zipper Kinase (MELK) inhibitors as potential anti-triple-negative breast cancer (MDA-MB-231 cell line) drug compounds
by: Hadiza Abdulrahman Lawal, et al.
Published: (2021-05-01)

Computational evaluation of potent 2-(1H-imidazol-2-yl) pyridine derivatives as potential V600E-BRAF inhibitors
by: Abdullahi Bello Umar, et al.
Published: (2020-11-01)

Docking-based strategy to design novel flavone-based arylamides as potent V600E-BRAF inhibitors with prediction of their drug-likeness and ADMET properties
by: Abdullahi Bello Umar, et al.
Published: (2020-10-01)

Dataset on insightful bio-evaluation of 2-(quinoline-4-yloxy)acetamide analogues as potential anti-Mycobacterium tuberculosis catalase-peroxidase agents via in silico mechanisms
by: Abel Kolawole Oyebamiji, et al.
Published: (2021-10-01)

MOLECULAR DOCKING AND QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP (QSAR) STUDIES OF SOME SELECTED ANTI-ULCER INHIBITORS
by: Muhammad Baba Muhammad, et al.
Published: (2019-03-01)

Computational modeling of novel quinazoline derivatives as potent epidermal growth factor receptor inhibitors
by: Muhammad Tukur Ibrahim, et al.
Published: (2020-02-01)

In silico studies of some 2-anilinopyrimidine derivatives as anti-triple-negative breast cancer agents
by: Hadiza Lawal Abdulrahman, et al.
Published: (2020-05-01)

Structure-based design of some quinazoline derivatives as epidermal growth factor receptor inhibitors
by: Muhammad Tukur Ibrahim, et al.
Published: (2020-11-01)

IN SILICO STUDY FOR INVESTIGATING AND PREDICTING THE ACTIVITIES OF 1,2,4-TRIAZOLE DERIVATIES AS POTENT ANTI-TUBERCULAR AGENTS
by: SHOLA ELIJAH ADENIJI, et al.
Published: (2018-07-01)

In silico modeling of tetraoxane-8-aminoquinoline hybrids active against Plasmodium falciparum
by: Aliyu Wappah Mahmud, et al.
Published: (2020-06-01)

In silico studies of 2,5-disubstituted furans as active antimalarial drug candidates
by: Aliyu Wappah Mahmud, et al.
Published: (2020-05-01)

Ligand-based drug design and molecular docking simulation studies of some novel anticancer compounds on MALME-3M melanoma cell line
by: Abdullahi Bello Umar, et al.
Published: (2021-01-01)

IN-SILICO STUDY FOR PREDICTING THE INHIBITION CONCENTRATION OF SOME HETEROCYCLIC AND PHENYLIC COMPOUNDS AS POTENT HERBICIDES USING THE MLR - GFA APPROACH
by: SAIDU TUKUR, et al.
Published: (2019-03-01)

COMPUTATIONAL STUDIES OF SOME BISCOUMARIN AND BISCOUMARIN THIOUREA DERIVATIVES AS ⍺-GLUCOSIDASE INHIBITORS
by: Muhammad Tukur Ibrahim, et al.
Published: (2018-07-01)

QSAR modelling and molecular docking studies for anti-cancer compounds against melanoma cell line SK-MEL-2
by: Abdullahi Bello Umar, et al.
Published: (2020-03-01)

Design of more potent quinazoline derivatives as EGFRWT inhibitors for the treatment of NSCLC: a computational approach
by: Muhammad Tukur Ibrahim, et al.
Published: (2021-07-01)

QSAR, molecular docking and ADMET properties in silico studies of novel 4,5,6,7-tetrahydrobenzo[D]-thiazol-2-Yl derivatives derived from dimedone as potent anti-tumor agents through inhibition of C-Met receptor tyrosine kinase
by: Ossama Daoui, et al.
Published: (2021-07-01)

In-silico molecular design and dynamic binding energy assessments of some multifunctional lubricating oil additives
by: Usman Abdulfatai, et al.
Published: (2020-04-01)

IN-SILICO STUDIES OF SOME INDOLE DERIVATIVES AS AN ANTI-HEPATITIS C DRUG.
by: Abubakar Sadiq Bello, et al.
Published: (2018-07-01)

In-silico activity prediction and docking studies of some 2, 9-disubstituted 8-phenylthio/phenylsulfinyl-9h-purine derivatives as Anti-proliferative agents
by: Muhammad Tukur Ibrahim, et al.
Published: (2020-01-01)

QSAR and molecular docking studies of novel 2,5-distributed-1,3,4-thiadiazole derivatives containing 5-phenyl-2-furan as fungicides against Phythophthora infestans
by: Yusuf Isyaku, et al.
Published: (2020-04-01)

Biological evaluation and pharmacokinetic profiling of a coumarin-benzothiazole hybrid as a new scaffold for human gliomas
by: Moustafa T. Gabr, et al.
Published: (2020-09-01)

Molecular docking studies, drug-likeness and in-silico ADMET prediction of some novel β-Amino alcohol grafted 1,4,5-trisubstituted 1,2,3-triazoles derivatives as elevators of p53 protein levels
by: Zakari Ya'u Ibrahim, et al.
Published: (2020-11-01)

QSAR and molecular docking studies of 1,3-dioxoisoindoline-4-aminoquinolines as potent antiplasmodium hybrid compounds
by: Aliyu Wappah Mahmud, et al.
Published: (2020-03-01)

INSILICO MODELLING ON SOME C14-UREA TETRANDRINE COMPOUNDS AS POTENT ANTI-CANCER AGAINST HUMAN ERYTHROLEUKEMIA (HEL) CELL LINE
by: Mustapha Abdullahi, et al.
Published: (2019-03-01)

Benzoquinoline Derivatives: A Straightforward and Efficient Route to Antibacterial and Antifungal Agents
by: Vasilichia Antoci, et al.
Published: (2021-04-01)

Computer-aided design of some quinazoline analogues as epidermal growth factor receptor inhibitors
by: Muhammad Tukur Ibrahim, et al.
Published: (2021-06-01)

Evaluation of phenylethylamine type entactogens and their metabolites relevant to ecotoxicology – a QSAR study
by: Takač Milena Jadrijević-Mladar, et al.
Published: (2019-12-01)

Computer-aided identification of a series of novel ligands showing high potency as hepatitis C virus NS3/4A protease inhibitors
by: Stephen Ejeh, et al.
Published: (2021-01-01)

A novel QSAR model for designing, evaluating,and predicting the anti-MES activity of new 1H-pyrazole-5-carboxylic acid derivatives
by: Adedirin Oluwaseye, et al.
Published: (2017-07-01)

In Silico Pharmacokinetics, ADMET Study and Conceptual DFT Analysis of Two Plant Cyclopeptides Isolated From Rosaceae as a Computational Peptidology Approach
by: Norma Flores-Holguín, et al.
Published: (2021-08-01)